Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The concentration of 25(OH)D in serum gradually decreased from the control group (29 ng/mL) to the groups with metabolic and affective disorders (18 to 19 ng/mL).

Source: 3.1. Cohort Characteristics and Metabolic: Psychometric Architecture. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

According to the study protocol, the participants were divided into four groups of 50 individuals each: (1) patients with type 2 diabetes mellitus diagnosed according to the criteria of the American Diabetes Association []; (2) patients with prediabetes (impaired glucose tolerance); (3) patients with depressive: anxiety disorders in the absence of clinical and laboratory signs of carbohydrate metabolism disorders; (4) apparently healthy controls without established somatic and mental pathology, who formed the control group.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Peripheral BDNF-TrkB Expression and Vitamin D Status in Depression, Prediabetes and Type 2 Diabetes: A Cross-Sectional Biomarker Study

Study design awaiting verification · Biomedicines · 2026

Original publication title

Peripheral BDNF: TrkB Expression and Vitamin D Status in Depression, Prediabetes and Type 2 Diabetes: A Cross-Sectional Biomarker Study

Oleksandr Pavlovych; Iryna Kamyshna; Larysa Pavlovych; Oleh Lushchak; Iryna Halabitska; Pavlo Petakh; Oleksandr Kamyshnyi

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Background/Objectives:

Depression and anxiety cluster with dysglycaemia along a prediabetes: type 2 diabetes continuum, but the signatures of affective and metabolic burden are unclear. We examined whether neurotrophin-related gene expression and 25(OH)D status track symptoms, parameters, or both.

Methods:

A cross-sectional study of 200 adults (n = 50 each: type 2 diabetes, prediabetes, depressive: anxiety, apparently healthy controls) was conducted. Anthropometry, glycaemic and lipid indices, PHQ-9, GAD-7, serum 25(OH)D and RT-qPCR expression of BDNF, NGF, NTRK1 and NTRK2 in whole peripheral blood were assessed. Multivariable regression, dominance analysis and pre-specified sensitivity analyses were applied.

Results:

BDNF, NGF and NTRK2 expression progressively decreased from controls to prediabetes and type 2 diabetes and was lowest in the depressive: anxiety group (p < 0.001); NTRK1 expression did not differ. Peripheral BDNF was more closely associated with PHQ-9 and 25(OH)D than with glycaemic or anthropometric indices. Psychiatric variables accounted for approximately 81% of the variance explained by the multivariable model (apparent R2 = 0.257), corresponding to approximately 21% of the total observed variance in log(BDNF).

Conclusions:

Peripheral BDNF and NTRK2 mRNA and 25(OH)D status were associated with depressive symptom burden more strongly than with metabolic parameters across a prediabetes: type 2 diabetes continuum. These associations describe an exploratory biomarker pattern; they do not establish altered signalling activity, causality or clinical utility, which require prospective validation.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Depression and anxiety cluster with dysglycaemia along a prediabetes: type 2 diabetes continuum, but the signatures of affective and metabolic burden are unclear. We examined whether neurotrophin-related gene expression and 25(OH)D status track symptoms, parameters, or both.

Source: Background/Objectives

Abstract: Results

BDNF, NGF and NTRK2 expression progressively decreased from controls to prediabetes and type 2 diabetes and was lowest in the depressive: anxiety group (p < 0.001); NTRK1 expression did not differ. Peripheral BDNF was more closely associated with PHQ-9 and 25(OH)D than with glycaemic or anthropometric indices. Psychiatric variables accounted for approximately 81% of the variance explained by the multivariable model (apparent R2 = 0.257), corresponding to approximately 21% of the total observed variance in log(BDNF).

Source: Results

Abstract: Conclusions

Peripheral BDNF and NTRK2 mRNA and 25(OH)D status were associated with depressive symptom burden more strongly than with metabolic parameters across a prediabetes: type 2 diabetes continuum. These associations describe an exploratory biomarker pattern; they do not establish altered signalling activity, causality or clinical utility, which require prospective validation.

Source: Conclusions
Authors’ abstract

Background/Objectives:

Depression and anxiety cluster with dysglycaemia along a prediabetes: type 2 diabetes continuum, but the signatures of affective and metabolic burden are unclear. We examined whether neurotrophin-related gene expression and 25(OH)D status track symptoms, parameters, or both.

Methods:

A cross-sectional study of 200 adults (n = 50 each: type 2 diabetes, prediabetes, depressive: anxiety, apparently healthy controls) was conducted. Anthropometry, glycaemic and lipid indices, PHQ-9, GAD-7, serum 25(OH)D and RT-qPCR expression of BDNF, NGF, NTRK1 and NTRK2 in whole peripheral blood were assessed. Multivariable regression, dominance analysis and pre-specified sensitivity analyses were applied.

Results:

BDNF, NGF and NTRK2 expression progressively decreased from controls to prediabetes and type 2 diabetes and was lowest in the depressive: anxiety group (p < 0.001); NTRK1 expression did not differ. Peripheral BDNF was more closely associated with PHQ-9 and 25(OH)D than with glycaemic or anthropometric indices. Psychiatric variables accounted for approximately 81% of the variance explained by the multivariable model (apparent R2 = 0.257), corresponding to approximately 21% of the total observed variance in log(BDNF).

Conclusions:

Peripheral BDNF and NTRK2 mRNA and 25(OH)D status were associated with depressive symptom burden more strongly than with metabolic parameters across a prediabetes: type 2 diabetes continuum. These associations describe an exploratory biomarker pattern; they do not establish altered signalling activity, causality or clinical utility, which require prospective validation.

Publication and source details

Original title: Peripheral BDNF: TrkB Expression and Vitamin D Status in Depression, Prediabetes and Type 2 Diabetes: A Cross-Sectional Biomarker Study

Oleksandr Pavlovych; Iryna Kamyshna; Larysa Pavlovych; Oleh Lushchak; Iryna Halabitska; Pavlo Petakh; Oleksandr Kamyshnyi

Biomedicines · 2026

* Correspondence: kamyshnyi_om@tdmu.edu.ua© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-08T08:19:43+00:00

DOI: 10.3390/biomedicines14092106 · PMC13604075